Genotypes of Pneumocystis jiroveci Isolates Obtained in Harare, Zimbabwe, and London, United Kingdom

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 12, 2003, Pages 3979-3981

  Miller, Robert F ^a   Lindley, Austin R ^b   Ambrose, Helen E ^b   Malin, Adam S ^c,d   Wakefield, Ann E ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^d ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIFAMOLE; DAPSONE; DIHYDROPTEROATE SYNTHASE;

ARTICLE; CONTROLLED STUDY; GENE LOCUS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PRESSURE; PRIORITY JOURNAL; PROPHYLAXIS; UNITED KINGDOM; ZIMBABWE;

GENOTYPE; GREAT BRITAIN; HIV INFECTIONS; HIV-1; HUMANS; LONDON; MYCOSES; PNEUMOCYSTIS; PNEUMOCYSTIS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL; RNA, VIRAL; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; ZIMBABWE;

EID: 0344011987     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.12.3979-3981.2003     Document Type: Article

References (20)

1. Anonymous. 1995. Co-trimoxazole use restricted. Drug Ther. Bull. 33:92-93.
2. Beard, C. B., J. L. Carter, S. P. Keely, L. Huang, N. J. Pieniazek, I. N. S. Moura, J. M. Roberts, A. W. Hightower, M. S. Bens, A. R. Freeman, S. Lee, J. R. Stringer, J. S. Duchin, C. del Rio, D. Rimland, R. P. Boughman, D. A. Levy, V. J. Dietz, P. Simon, and T. R. Navin. 2000. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg. Infect. Dis. 6:265-272.
3. Huang, L., J. Friedly, A. M. Morris, J. E. Carter, J. R. Turner, C. Merrifield, T. Navin, and C. B. Beard. 2001. Pneumocystis carinii dihydropteroate synthase genotypes in HIV-infected persons residing in San Francisco: possible implications for disease transmission. J. Eukaryot. Microbiol. 48(Suppl.): 137S-138S.
4. Kazanijian, P., W. Armstrong, P. A. Hossler, W. Burman, J. Richardson, C.-H. Lee, L. Crane, J. Katz, and S. R. Meshnick. 2000. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J. Infect. Dis. 182:551-557.
5. Keely, S. P., R. P. Baughman, A. G. Smulian, M. N. Dohn, and J. R. Stringer. 1996. Source of Pneumocystis carinii in recurrent episodes of pneumonia in AIDS patients. AIDS 10:881-888.
6. Keely, S. P., J. R. Stringer, R. P. Baughman, M. J. Linke, P. D. Walzer, and A. G. Smulian. 1995. Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis. J. Infect. Dis. 172:595-598.
7. Lane, B. R., J. C. Ast, P. A. Hossler, D. P. Mindell, M. S. Bartlett, J. W. Smith, and S. R. Meshnick. 1997. Dihydropteroate synthase polymorphisms in pneumocystis carinii. J. Infect. Dis. 177:482-485.
8. Ma, L., L. Borio, H. Masur, and J. A. Kovacs. 1999. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J. Infect. Dis. 180:1969-1978.
9. Malin, A. S., L. K. Z. Gwanzura, S. Klein, V. J. Robertson, P. Musvaire, and P. R. Mason. 1995. Pneumocystis carinii pneumonia in Zimbabwe. Lancet 346:1258-1261.
10. Maskell, N. A., D. J. Waine, A. Lindley, J. C. T. Peperall, A. E. Wakefield, R. F. Miller, and R. J. O. Davies. 2003. Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy. Thorax 58:594-597.
11. Miller, R. F. 1994. Prevention and treatment of Pneumocystis carinii pneumonia in patients infected with HIV. Drug Ther. Bull. 32:12-15.
12. Miller, R. F. 2000. Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing? Thorax 55(Suppl. 1):S15-S22.
13. Miller, R. F., H. E. Ambrose, and A. E. Wakefield. 2001. Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia. J. Clin. Microbiol. 39:3877-3882.
14. Ministry of Health and Child Welfare. 1994. Essential drugs list for Zimbabwe (EDLIZ), 3rd ed. Ministry of Health and Child Welfare, Harare, Zimbabwe.
15. Morris, A. M., M. Swanson, H. Ha, and L. Huang. 2000. Geographic distribution of human immunodeficiency virus-associated Pneumocystis carinii pneumonia in San Francisco. Am. J. Respir. Crit. Care Med. 162:1622-1626.
16. Stringer, J. R., C. B. Beard, R. F. Miller, and A. E. Wakefield. 2002. A new name (Pneumocystis jiroveci) for pneumocystis from humans. Emerg. Infect. Dis. 8:891-896.
17. Stringer, J. R., M. T. Cushion, and A. E. Wakefield. 2001. New nomenclature for the genus Pneumocystis. J. Eukaryot. Microbiol. 49 (Suppl.):184S-189S.
18. Tsolaki, A. G., P. Beckers, and A. E. Wakefield. 1998. Pre-AIDS era isolates of Pneumocystis carinii f. sp. hominis: high genotypic similarity with contemporary isolates. J. Clin. Microbiol. 36:90-93.
19. Wakefield, A. E., A. R. Lindley, H. E. Ambrose, C.-M. Denis, and R. F. Miller. 2003. Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients. J. Infect. Dis. 187:901-908.
20. Wakefield, A. E., F. J. Pixley, S. Banerji, K. Sinclair, R. F. Miller, E. R. Moxon, and J. M. Hopkin. 1990. Detection of Pneumocystis carinii with DNA amplification. Lancet 336:451-453.